The prognosis of patients with glioblastoma (GBM) remains poor, and the use of
hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit …

Background: Hypofractionated radiotherapy (HFR) is sometimes used in the treatment of
glioblastoma multiforme (GBM). The efficacy and safety of HFR is still under investigation …

PURPOSE: A pilot study was designed to evaluate the safety and efficacy of a novel regimen
of hypofractionated intensity-modulated radiotherapy (RT) in the adjuvant treatment of …

Objectives Glioblastoma (GBM) is the most common malignant primary brain tumour in
adults. Surgery and radiotherapy constitute the cornerstones for the therapeutic …

Background The aim of this retrospective registry-based Danish patterns of care study was
(1) to evaluate the real-world utilisation of short-course hypofractionated radiotherapy …

PURPOSE: Despite major advances in treatment modalities, the prognosis of patients with
glioblastoma multiforme (GBM) remains poor. Exploring hypofractionated regimens to …

Because of promising radiobiological advantages allowing dose escalation and/or reduction
of treatment time, hyperfractionated and accelerated‐hyperfractionated radiotherapy (hf‐rt …

This study evaluated practice patterns, outcomes, and predictors of survival with respect to
the addition of chemotherapy to definitive hypofractionated radiation therapy (HFRT) for …

Surgery and radiotherapy are the mainstay of treatment of patients with malignant glioma.
Additional adjuvant chemotherapy showed at best a moderate improvement of survival for …

PURPOSE: To evaluate the outcome for elderly or younger poor prognosis glioblastoma
patients treated with hypofractionated radiotherapy (HypoRT). METHODS AND MATERIALS …